Similar articles

• [Angiogenic inducers and inhibitors].

  Shukunami C, Hiraki Y. Shukunami C, et al. Tanpakushitsu Kakusan Koso. 2000 Sep;45(13 Suppl):2131-8. Tanpakushitsu Kakusan Koso. 2000. PMID: 11021214 Review. Japanese. No abstract available.
• The clinical implications of angiogenesis in the treatment of cancer.

  Aoun E, Taher A. Aoun E, et al. J Med Liban. 2002 Jan-Apr;50(1-2):32-8. J Med Liban. 2002. PMID: 12841311 Review.
• Selective functions of angiopoietins and vascular endothelial growth factor on blood vessels: the concept of "vascular domain".

  Sato TN, Loughna S, Davis EC, Visconti RP, Richardson CD. Sato TN, et al. Cold Spring Harb Symp Quant Biol. 2002;67:171-80. doi: 10.1101/sqb.2002.67.171. Cold Spring Harb Symp Quant Biol. 2002. PMID: 12858538 No abstract available.
• Protective role of angiopoietin-1 in experimental pulmonary hypertension.

  Zhao YD, Campbell AI, Robb M, Ng D, Stewart DJ. Zhao YD, et al. Circ Res. 2003 May 16;92(9):984-91. doi: 10.1161/01.RES.0000070587.79937.F0. Epub 2003 Apr 10. Circ Res. 2003. PMID: 12690034
• [Eye and pathologic angiogenesis].

  Ishibashi T. Ishibashi T. Fukuoka Igaku Zasshi. 2000 Nov;91(11):277-83. Fukuoka Igaku Zasshi. 2000. PMID: 11187718 Review. Japanese. No abstract available.